Stay updated on Dupilumab for Chronic Hands Eczema - Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for Chronic Hands Eczema - Clinical Trial page.

Latest updates to the Dupilumab for Chronic Hands Eczema - Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study page presents details for the completed DUPECZEMAIN trial of dupilumab for chronic hand eczema, including participant criteria, treatment arms, and measured outcomes.SummaryDifference48%

- Check19 days agoChange DetectedThe site revision shown in the footer changed from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedAn NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” during a transition. The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check47 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now shows a 403 Forbidden error for the study record, replacing the previous content with an access-denied message and standard site chrome; the study details are no longer visible in this view.SummaryDifference18%

- Check68 days agoChange DetectedThe page now shows Revision: v3.7.0 to reflect the latest document version, and the older Revision: v3.6.6 label has been removed.SummaryDifference0.1%

Stay in the know with updates to Dupilumab for Chronic Hands Eczema - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for Chronic Hands Eczema - Clinical Trial page.